These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32557716)

  • 1. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
    Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
    J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease.
    Wang J; Li SC; Ye Q; Gao LL; Nie YM; Xu H; Wu M; Cao P; Wang Y
    J Clin Pharmacol; 2020 Sep; 60(9):1220-1230. PubMed ID: 32488878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic analysis for dose regimen optimization of vancomycin in Southern Chinese children.
    Shen X; Li X; Lu J; Zhu J; He Y; Zhang Z; Chen Z; Zhang J; Fan X; Li W
    CPT Pharmacometrics Syst Pharmacol; 2024 Jul; 13(7):1201-1213. PubMed ID: 38686551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetics and Dose Optimization of Vancomycin in Critically Ill Children.
    Sridharan K; Abbasi MY; Mulubwa M
    Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):539-546. PubMed ID: 34156647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation.
    Frymoyer A; Hersh AL; Coralic Z; Benet LZ; Joseph Guglielmo B
    Clin Ther; 2010 Mar; 32(3):534-42. PubMed ID: 20399990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis.
    Deng C; Liu T; Zhou T; Lu H; Cheng D; Zhong X; Lu W
    Int J Clin Pharmacol Ther; 2013 May; 51(5):407-15. PubMed ID: 23458230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Pediatric Liver Transplant Recipients.
    Shoji K; Saito J; Nakagawa H; Funaki T; Fukuda A; Sakamoto S; Kasahara M; Momper JD; Capparelli EV; Miyairi I
    Microbiol Spectr; 2021 Oct; 9(2):e0046021. PubMed ID: 34612690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes.
    Vu DH; Nguyen DA; Delattre IK; Ho TT; Do HG; Pham HN; Dao XC; Tran NT; Nguyen GB; Van Bambeke F; Tulkens PM; Nguyen HA
    Int J Antimicrob Agents; 2019 Dec; 54(6):702-708. PubMed ID: 31600554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance.
    He CY; Ye PP; Liu B; Song L; van den Anker J; Zhao W
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0089721. PubMed ID: 34339268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing.
    Tang Z; Guan J; Li J; Yu Y; Qian M; Cao J; Shuai W; Jiao Z
    Int J Antimicrob Agents; 2021 Mar; 57(3):106300. PubMed ID: 33567334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved vancomycin dosing in children using area under the curve exposure.
    Le J; Bradley JS; Murray W; Romanowski GL; Tran TT; Nguyen N; Cho S; Natale S; Bui I; Tran TM; Capparelli EV
    Pediatr Infect Dis J; 2013 Apr; 32(4):e155-63. PubMed ID: 23340565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/pharmacodynamic analysis.
    Fernández de Gatta Mdel M; Santos Buelga D; Sánchez Navarro A; Dominguez-Gil A; García MJ
    Clin Pharmacokinet; 2009; 48(4):273-80. PubMed ID: 19492872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function.
    Liu TT; Pang HM; Jing L; Wei WX; Qin XL; Guo Q; Lu H; Cheng DH; Jiang WZ
    J Pharm Pharmacol; 2019 Jun; 71(6):945-955. PubMed ID: 30873627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
    Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
    Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation.
    Revilla N; Martín-Suárez A; Pérez MP; González FM; Fernández de Gatta Mdel M
    Br J Clin Pharmacol; 2010 Aug; 70(2):201-12. PubMed ID: 20653673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy.
    Chen CY; Zhou Y; Cui YM; Yang T; Zhao X; Wu Y
    J Clin Pharm Ther; 2019 Apr; 44(2):300-311. PubMed ID: 30636182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Population Pharmacokinetics Model for Vancomycin Dosage Optimization Based on Serum Cystatin C.
    Lu JJ; Chen M; Lv CL; Zhang R; Lu H; Cheng DH; Tang SY; Liu TT
    Eur J Drug Metab Pharmacokinet; 2020 Aug; 45(4):535-546. PubMed ID: 32304024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
    Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
    J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy.
    Moffett BS; Morris J; Munoz F; Arikan AA
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1089-1097. PubMed ID: 30937470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients.
    Chen J; Huang X; Bu S; Chen X; Zhou J; Liu X; Guo X; Li L; Zhang J
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00885. PubMed ID: 34664790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.